Dr. Villasboas Bisneto is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
200 1st Street SW
Rochester, MN 55905- Is this information wrong?
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2013 - 2017
- University of Miami/Jackson Health SystemResidency, Internal Medicine, 2009 - 2013
- Federal University of Bahia Faculty of MedicineClass of 2008, MD
Certifications & Licensure
- MN State Medical License 2013 - 2024
- FL State Medical License 2012 - 2014
Clinical Trials
Publications & Presentations
PubMed
- 6 citationsProcalcitonin as a biomarker for predicting bacterial infection in chimeric antigen receptor T-cell therapy recipients.Marissa Z Powell, Kristin C Mara, Radhika Bansal, Matthew A Hathcock, Arushi Khurana, N Nora Bennani, Yucai Wang, Jonas Paludo, Jose Villasboas Bisneto, Stephen M Anse...> ;Cancer Medicine. 2023 Apr 1
- 14 citationsMetabolic characteristics and prognostic differentiation of aggressive lymphoma using one-month post-CAR-T FDG PET/CT.William G Breen, Matthew A Hathcock, Jason R Young, Roman O Kowalchuk, Radhika Bansal, Arushi Khurana, N Nora Bennani, Jonas Paludo, Jose C Villasboas Bisneto, Yucai W...> ;Journal of Hematology & Oncology. 2022 Mar 26
- 22 citationsDoes bridging radiation therapy affect the pattern of failure after CAR T-cell therapy in non-Hodgkin lymphoma?Omran Saifi, William G Breen, Scott C Lester, William G Rule, Bradley Stish, Allison Rosenthal, Javier Munoz, Steven M Herchko, Hemant S Murthy, Yi Lin, Radhika Bansal...> ;Radiotherapy and Oncology. 2022 Jan 1
- Join now to see all
Abstracts/Posters
- Tumor ADAM10/ADAM17-Mediated PD-L1 Loss May Predict Poor Outcomes in Diffuse Large B Cell LymphomaJose Villasboas, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Mass Cytometry Identifies a Novel Signature for Myeloid-Derived Suppressor-Cells in WaldenstromÍs MacroglobulinemiaJose Villasboas, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Patient Experience of Chimeric Antigen Receptor (CAR)-T Cell Therapy Vs. Stem Cell Transplant: Longitudinal Patient Reported Adverse Events, Cognition and Quality of LifeJose Villasboas, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Other Languages
- Portuguese, Spanish
Hospital Affiliations
- Mayo Clinic Hospital - RochesterRochester, Minnesota
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: